after 12 weeks of treatment with sulfasalazine , elevated levels of circulating activated lymphocytes and abnormal ex vivo mitogen response to concanavalin a ( con-a ) in 11 patients with ra reverted to normal .
C0036078
sulfasalazine
C0003873
ra